Abstract
The diagnosis of gestational diabetes mellitus (GDM) is important to prevent maternal and neonatal complications. This study aimed to investigate the feasibility of parameters of glycaemic variability to predict neonatal complications in women with GDM. A retrospective study was conducted on pregnant women tested positive at the oral glucose tolerance test (OGTT) during 16–18 or 24–28 weeks of gestation. Glycaemic measures were extracted from patients’ glucometers and expanded to obtain parameters of glycaemic variability. Data on pregnancy outcomes were obtained from clinical folders. Descriptive group-level analysis was used to assess trends in glycaemic measures and foetal outcomes. Twelve patients were included and analysed, accounting for 111 weeks of observations. The analysis of trends in parameters of glycaemic variability showed spikes of glycaemic mean, high blood glucose index and J-index at 30–31 weeks of gestation for cases with foetal macrosomia, defined as foetal growth >90° percentile, neonatal hypoglycaemia and hyperbilirubinemia. Specific trends in parameters of glycaemic variability observed at third trimester correlate with foetal outcomes. Further research is awaited to provide evidence that monitoring of glycaemic variability trends could be more clinically informative and useful than standard glycaemic checks to manage women with GDM at delivery.
Publisher
Public Library of Science (PLoS)
Reference47 articles.
1. The epidemiology of diabetes and pregnancy in the U.S., 1988;MM Engelgau;Diabetes Care,1995
2. Gestational diabetes mellitus;SL Kjos;N Engl J Med,1999
3. Hyperglycaemia and adverse pregnancy outcome;HAPO Study Cooperative Research Group;N Engl J Med,2008
4. Glycemic variability. Should we and can we prevent it?;L Monnier;Diabetes Care,2008
5. Maternal glycemia and risk of large-for-gestational age babies in a population based screening;Z Kerenyi;Diabetes Care,2009